Related Experiment Video

Updated: Aug 17, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Revascularization of diabetic patients: are drug-eluting stents the solution?

Giulio Guagliumi1, Giuseppe Musumeci

  • 1Interventional Catheterization Laboratory, Cardiovascular Department, Ospedali Riuniti, Bergamo, Italy. guagliumig@interfree.it

Italian Heart Journal : Official Journal of the Italian Federation of Cardiology
|July 13, 2005
PubMed

Insights

Drug-eluting stents (DES) reduce repeat procedures after coronary stenting in diabetic patients. However, diabetes still increases major adverse cardiac events (MACE), highlighting the need for integrated treatment strategies.

Area of Science:

  • Cardiology
  • Endocrinology
  • Biomedical Engineering

Background:

  • Coronary stenting in diabetic patients is associated with higher rates of restenosis, repeat revascularization, and major adverse cardiac events (MACE) compared to non-diabetic individuals.
  • The efficacy of drug-eluting stents (DES) in this high-risk population is under ongoing investigation.

Purpose of the Study:

  • To evaluate the clinical benefit and outcomes of DES in diabetic patients undergoing coronary stenting.
  • To compare the effectiveness of DES against control groups in reducing MACE and target lesion revascularization.

Main Methods:

  • Review of randomized clinical trials and real-world post-approval registries evaluating Cypher and Taxus DES.
  • Analysis of mid- and long-term follow-up data comparing outcomes in diabetic versus non-diabetic patients.

Main Results:

  • DES demonstrated a substantial reduction in MACE and target lesion revascularization compared to control patients.
  • Despite DES use, diabetes remained an independent predictor of increased MACE at mid- and long-term follow-up.

Conclusions:

  • While DES improve outcomes, diabetic patients undergoing coronary stenting still face a significant unmet need for better management.
  • Integrated approaches involving medical, glycemic, and device therapy are crucial for optimizing outcomes in diabetic patients.
  • Further prospective, randomized studies are needed to compare DES with surgical revascularization, particularly in complex multi-vessel or left main disease.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...